Postnatal cardiovascular morbidity following preterm pre-eclampsia: An observational study.

Diastolic dysfunction Echocardiography Left ventricular remodelling Postpartum Pre-eclampsia

Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 10 03 2022
revised: 10 08 2022
accepted: 11 08 2022
pubmed: 28 8 2022
medline: 1 12 2022
entrez: 27 8 2022
Statut: ppublish

Résumé

To explore the nature of postnatal cardiovascular morbidity following pregnancies complicated by preterm pre-eclampsia and investigate associations between pregnancy characteristics and maternal postnatal cardiovascular function. This was an observational sub-study of a single-centre feasibility randomised double-blind placebo-controlled trial (https://www. gov; NCT03466333), involving women with preterm pre-eclampsia, delivering before 37 weeks. Eligible women underwent echocardiography, arteriography and blood pressure monitoring within three days of birth, six weeks and six months postpartum. Correlations between pregnancy and cardiovascular characteristics were assessed using Spearman's correlation. The prevalence of cardiovascular dysfunction and remodelling six months following preterm pre-eclampsia. Forty-four women completed the study. At six months, 27 (61 %) had diastolic dysfunction, 33 (75 %) had raised total vascular resistance (TVR) and 18 (41 %) had left ventricular remodelling. Sixteen (46 %) women had de novo hypertension by six months and only two (5 %) women had a completely normal echocardiogram. Echocardiography did not change significantly from six weeks to six months. Earlier gestation at delivery and lower birthweight centile were associated with worse six-month diastolic dysfunction (E/E': rho = -0.39, p = 0.001 & rho = -0.42, p = 0.005) and TVR (rho = -0.34, p = 0.02 & rho = -0.37, p = 0.01). Preterm pre-eclampsia is associated with persistent cardiovascular morbidity-six months postpartum in the majority of women. These cardiovascular changes have significant implications for long-term cardiovascular health. The graded severity of diastolic dysfunction and TVR with worsening pre-eclampsia phenotype suggests a dose-effect. However, the mechanistic link remains uncertain.

Identifiants

pubmed: 36029727
pii: S2210-7789(22)00089-7
doi: 10.1016/j.preghy.2022.08.007
pii:
doi:

Types de publication

Randomized Controlled Trial Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-81

Subventions

Organisme : Medical Research Council
ID : MR/R001693/1
Pays : United Kingdom

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Laura Ormesher (L)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, University of Manchester, UK; Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: laura.ormesher@manchester.ac.uk.

Suzanne Higson (S)

Manchester Heart Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Matthew Luckie (M)

Manchester Heart Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Stephen A Roberts (SA)

Centre for Biostatistics, University of Manchester, UK.

Heather Glossop (H)

Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Andrew Trafford (A)

Division of Cardiovascular Sciences, University of Manchester, UK.

Elizabeth Cottrell (E)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, University of Manchester, UK.

Edward D Johnstone (ED)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, University of Manchester, UK; Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Jenny E Myers (JE)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, University of Manchester, UK; Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH